NCT03970304View on ClinicalTrials.gov

CVD 37000: Immunity and Microbiome Studies At Intestinal and Systemic Sites in Ty21a Vaccinated Adults

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

October 24, 2013

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2027

Conditions
Typhoid Vaccination
Interventions
DRUG

Vivotif Typhoid Oral Vaccine

The 4 doses (1 capsule each) will be administered on alternate days, e.g., days 0, 2, 4, and 7 (± 1 day) under the supervision of the study coordinator(s).

Trial Locations (1)

21201

Universtiy of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER